Acquisition Announced
Sanofi acquisition of Dynavax Technologies
US$2.2bn equity value
Announced 23 Dec 2025 · US$15.50 cash per share
Advisers
Dynavax Technologies
Target
- Financial adviser
- Legal adviser
- Fairness opinion
- Target
- Dynavax Technologies
- Acquirer
- Samba Merger Sub
- Target based in
- United States
- Buyer based in
- France
- Sector
- Biotech
- Tags
- Biotech, Pharma
In the league tables
Similar deals
- Eli Lilly and Company acquisition of Orna Therapeutics Feb 2026 · US$2.4bn · Biotech
- Servier acquisition of Day One Biopharmaceuticals Mar 2026 · US$2.5bn · Biotech
- Fresenius acquisition of mAbxience Oct 2026 · US$1.9bn · Biotech
- Chiesi Group acquisition of KalVista Pharmaceuticals Apr 2026 · US$1.9bn · Pharma
- Neurocrine Biosciences acquisition of Soleno Therapeutics Apr 2026 · US$2.9bn · Biotech
Sources
- 24 Dec 2025 Sanofi — Sanofi acquisition of Dynavax Technologies sanofi.com
- 12 Jan 2026 Tender offer statement (SC TO-T), DYNAVAX TECHNOLOGIES CORP sec.gov
- 12 Jan 2026 Target response to tender offer (SC 14D9), DYNAVAX TECHNOLOGIES CORP sec.gov


